Rhonda Duffy

Chief Operating Officer

Rhonda Duffy is responsible for leading Biocon Biologics’ global operations functions, manufacturing, MSAT, quality, supply chain management and projects.

Rhonda joined Biocon Biologics in July 2023, bringing with her over 30 years of experience in establishing new functions, bringing new skills and competencies into the organizations she has worked in, and sorting out challenging areas where stabilization and improved output in quality, supply and performance are required. She has been successful in raising quality standards, adding technology upgrades, stabilizing, and improving performance and output in all sites, while building new supply chains with external contract manufacturers. She has worked closely with R&D to develop and launch new products. Rhonda has also managed large, diverse global teams across multiple sites and product lines.

Prior to joining Biocon Biologics, Rhonda worked with Leo Pharma (a Denmark-based global dermatology leader), for over 30 years. Most recently, as Executive Vice President for Global Product Supply at Leo Pharma, she led end-to-end product supply operations spanning 6 sites and 30 contract manufacturers, the launch of two biologics and the entire Global Product Supply for their product portfolio worth EUR1.3 billion in sales. Rhonda also spearheaded an ambitious and effective cost optimization program, oversaw a significant upgrade to several global manufacturing sites and built a new U.S.-based external supply network.

Rhonda is a qualified pharmacist with a PhD in Pharmacognosy from Trinity College, Dublin, UK.

Related Links

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics EU Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics U.S. Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Leaving the Biocon Biologics site

You are now leaving the Biocon Biologics page for a Biocon Biologics affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.